GNH USA

Europe — EMA

Memantina Maxmind

GNH USA supplies Memantina Maxmind (Memantine Hydrochloride), an NMDA receptor antagonist for moderate‑severe Alzheimer’s disease. Request a quote for supply.

Memantine Hydrochloride

Request sourcing

1
Pack/s

What is Memantine Hydrochloride?

Memantine Hydrochloride, the active ingredient in Memantina Maxmind, is a NMDA receptor antagonist presented as an oral tablet for oral use. It is used to treat moderate to severe Alzheimer’s disease in adults. GNH USA supplies Memantina Maxmind as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Memantine Hydrochloride used for?

Memantina Maxmind acts on the glutamatergic pathway to manage neurodegenerative disease. - Alzheimer’s disease (moderate to severe): helps improve cognition, daily functioning and slows symptom progression.

What are the side effects of Memantine Hydrochloride?

Memantina Maxmind may cause a range of adverse reactions.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness. - Headache: mild to moderate head pain. - Constipation: reduced bowel movements. - Confusion: transient disorientation. - Fatigue: feeling unusually tired. - Hypertension: elevated blood pressure.

Serious or Rare Side Effects: - Seizures: convulsive episodes requiring medical attention. - Severe allergic reaction: rash, swelling, or difficulty breathing. - Hallucinations: visual or auditory disturbances. - Cardiac arrhythmia: irregular heart rhythm. - Stevens‑Johnson syndrome: severe skin blistering.

What precautions apply to Memantine Hydrochloride?

Before prescribing Memantina Maxmind, consider the following safety measures. - Renal impairment: adjust dose or monitor renal function. - Hepatic impairment: use with caution in liver disease. - History of seizures: evaluate risk versus benefit. - Concomitant NMDA antagonists: avoid combined use. - Pregnancy and lactation: safety not established; weigh risks. - Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

What does Memantine Hydrochloride interact with?

Memantina Maxmind can interact with several medicines; monitoring is essential.

Major Interactions (Avoid): - Amantadine: additive NMDA antagonism may increase toxicity. - Dextromethorphan: combined use can enhance neuropsychiatric effects. - Ketamine: may potentiate central nervous system depression.

Moderate Interactions (Monitor Closely): - Antihypertensives: possible additive blood pressure lowering. - Anticholinergic agents: may worsen cognitive side effects. - Diuretics: monitor electrolytes and renal function.

Frequently asked questions

What is Memantina Maxmind used for?+
Memantina Maxmind contains memantine hydrochloride and is indicated for the treatment of moderate to severe Alzheimer’s disease. It helps improve cognitive function and daily activities by reducing excitotoxic neuronal damage associated with the disease.
How does memantine hydrochloride work?+
Memantine hydrochloride acts as a non‑competitive antagonist at the NMDA receptor, blocking excessive calcium influx caused by overstimulation of glutamate. This reduces excitotoxic neuronal injury and helps preserve synaptic function in patients with Alzheimer’s disease.
What is the usual dose of Memantina Maxmind?+
The dosage of Memantina Maxmind is determined by the prescribing clinician based on the patient’s clinical condition, renal function and tolerability. The prescriber will set the appropriate dose and titration schedule.
Is Memantina Maxmind safe during pregnancy or breastfeeding?+
Safety data for memantine hydrochloride in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision should be made by the treating physician.
How do I order Memantina Maxmind from GNH USA?+
To order Memantina Maxmind, submit an enquiry on the product page at gnh-usa.com specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Memantina Maxmind compare with other Alzheimer’s drugs?+
Memantine belongs to the NMDA receptor antagonist class, differing from cholinesterase inhibitors such as donepezil. While cholinesterase inhibitors enhance acetylcholine activity, memantine reduces glutamate‑mediated excitotoxicity. Both classes may be used together for complementary effects in moderate to severe Alzheimer’s disease.
What are the storage requirements for Memantina Maxmind?+
Memantina Maxmind should be stored at ambient temperature below 25 °C, in the original packaging, and protected from moisture and direct sunlight to maintain product stability.
How is Memantina Maxmind administered?+
Memantina Maxmind is taken orally, usually once daily after a gradual dose‑escalation period as directed by the prescriber. The tablets should be swallowed whole with water and not crushed or chewed.
What are the most serious risks associated with Memantina Maxmind?+
Serious risks include seizures, severe allergic reactions (such as anaphylaxis or Stevens‑Johnson syndrome), hallucinations, and cardiac arrhythmias. Patients should be monitored for these events, and any sudden changes in neurological or cardiac status should prompt immediate medical evaluation.
Who should not use Memantina Maxmind?+
Memantina Maxmind is contraindicated in patients with known hypersensitivity to memantine hydrochloride or any of its excipients. Caution is advised in individuals with severe renal impairment, uncontrolled seizures, or those taking other NMDA antagonists.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Memantine Hydrochloride
Route
Oral Use
Manufacturer
Maxmind Pharmaceutical Gmbh
Origin
EU

Related products